Aeglea aims to raise $60M for treating rare diseases – Austin Business Journal
Aeglea aims to raise $60M for treating rare diseases Austin Business Journal Aeglea BioTherapeutics Inc., an Austin-based biotechnology company developing treatments for rare genetic diseases and cancer, plans to raise $60 million … … Continue reading →
Aeglea aims to raise $60M for treating rare diseases – Austin Business Journal Read More »
